US Senator Sanders asks why drug, once free, now costs $375k

U.S. Senator Bernie Sanders sent a letter to Catalyst Pharmaceuticals on Monday asking it to justify its decision to charge $375,000 annually for a medication that for years has been available to patients for free. The drug, Firdapse, is used to treat Lambert-Eaton Myasthenic Syndrome (LEMS), a rare...

The post US Senator Sanders asks why drug, once free, now costs $375k appeared first on Raw Story.